Abstract
Although the exact nature of the relationship between calcium and the pathogenesis of Duchenne muscular dystrophy (DMD) is not fully understood, this is an important issue which has been addressed in several recent reviews (Alderton and Steinhardt, 2000a, Gailly, 2002, Allen et al., 2005). A key question when trying to understand the cellular basis of DMD is how the absence or low level of expression of dystrophin, a cytoskeletal protein, results in the slow but progressive necrosis of muscle fibres. Although loss of cytoskeletal and sarcolemmal integrity which results from the absence of dystrophin clearly plays a key role in the pathogenesis associated with DMD, a number of lines of evidence also establish a role for misregulation of calcium ions in the DMD pathology, particularly in the cytoplasmic space just under the sarcolemma. A number of calcium-permeable channels have been identified which can exhibit greater activity in dystrophic muscle cells, and existing evidence suggests that these may represent different variants of the same channel type (perhaps the transient receptor potential channel, TRPC). In addition, a prominent role for calcium-activated proteases in the DMD pathology has been established, as well as modulation of other intracellular regulatory proteins and signaling pathways. Whether dystrophin and its associated proteins have a direct role in the regulation of calcium ions, calcium channels or intracellular calcium stores, or indirectly alters calcium regulation through enhancement of membrane tearing, remains unclear. Here we focus on areas of consensus or divergence amongst the existing literature, and propose areas where future research would be especially valuable
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Reference
Acsadi, G., Dickson, G., Love, D.R., Jani, A., Walsh, F.S., Gurusinghe, A., Wolff, J.A., and Davies, K.E., 1991, Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs, Nature, 352, pp 815–818.
Alderton, J.M., and Steinhardt, R.A., 2000a, How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes, Trends Cardiovasc Med, 10, pp 268–272.
Alderton, J.M., and Steinhardt, R.A., 2000b, Calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes, J Biol Chem, 275, pp 9452–9460.
Allamand, V., and Campbell, K.P., 2000, Animal models for muscular dystrophy: valuable tools for the development of therapies, Hum Mol Genet, 9, pp 2459–2467.
Allen, D.G., Whitehead, N.P., and Yeung, E.W., 2005, Mechanisms of stretch-induced muscle damage in normal and dystrophic muscle: role of ionic changes, J Physiol, 567, pp 723–735.
Amalfitano, A., Rafael, J.A., and Chamberlain, J.S., 1997, Structure and mutation of the dystrophin gene. In: Dystrophin: Gene, Protein and Cell Biology (S. Brown and J.A. Lucy, eds) Cambridge University Press, Cambridge, UK, pp 1–26.
Anderson, J.T., Rogers, R.P., and Jarrett, H.W., 1996, Ca2+-calmodulin binds to the carboxyl-terminal domain of dystrophin, J Biol Chem, 271, pp 6605–6610.
Badalamente, M.A., and Stracher, A., 2000, Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition, Muscle Nerve, 23, pp 106–111.
Bakker, A.J., Head, S.I., Williams, D.A., and Stephenson, D.G., 1993, Ca2+ levels in myotubes grown from the skeletal muscle of dystrophic (mdx) and normal mice, J Physiol, 460, pp 1–13.
Bansal, D., Miyake, K., Vogel, S.S., Groh, S., Chen, C.C., Williamson, R., McNeil, P.L., and Campbell,K.P., 2003, Defective membrane repair in dysferlin-deficient muscular dystrophy, Nature, 423, pp 168–172.
Barnea, E., Zuk, D., Simantov, R., Nudel, U., and Yaffe, D., 1990, Specificity of expression of the muscle and brain dystrophin gene promoters in muscle and brain cells, Neuron, 5, pp 881–888.
Basset, O., Boittin, F.X., Cognard, C., Constantin, B., and Ruegg, U.T., 2006, Bcl-2 overexpression prevents calcium overload and subsequent apoptosis in dystrophic myotubes, Biochem J, 395, pp 267–276.
Basset, O., Boittin, F.X., Dorchies, O.M., Chatton, J.Y., van Breemen, C., and Ruegg, U.T., 2004, Involvement of inositol 1,4,5-trisphosphate in nicotinic calcium responses in dystrophic myotubes assessed by near-plasma membrane calcium measurement, J Biol Chem, 279, pp 47092–47100.
Baumbach, L.L., Chamberlain, J.S., Ward, P.A., Farwell, N.J., and Caskey, C.T., 1989, Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies, Neurology, 39, pp 465–474.
Beggs, A.H., Koenig, M., Boyce, F.M., and Kunkel, L.M., 1990, Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction, Hum Genet, 86, pp 45–48.
Beggs, A.H., and Kunkel, L.M., 1990, Improved diagnosis of Duchenne/Becker muscular dystrophy, JClin Invest, 85, pp 613–619.
Bell, C.D., and Conen, P.E., 1968, Histopathological changes in Duchenne muscular dystrophy, J Neurol Sci, 7, pp 529–544.
Bessou, C., Giugia, J.B., Franks, C.J., Holden-Dye, L., and Segalat, L., 1998, Mutations in the Caenorhabditis elegans dystrophin-like gene dys-1 lead to hyperactivity and suggest a link with cholinergic transmission, Neurogenetics, 2, pp 61–72.
Bies, R.D., Caskey, C.T., and Fenwick, R., 1992a, An intact cysteine-rich domain is required for dystrophin function, J Clin Invest, 90, pp 666–672.
Bies, R.D., Phelps, S.F., Cortez, M.D., Roberts, R., Caskey, C.T., and Chamberlain, J.S., 1992b, Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development, Nucleic Acids Res, 20, pp 1725–1731.
Blake, D.J., Love, D.R., Tinsley, J., Morris, G.E., Turley, H., Gatter, K., Dickson, G., Edwards, Y.H., and Davies, K.E., 1992, Characterization of a 4.8kb transcript from the Duchenne muscular dystrophy locus expressed in Schwannoma cells, Hum Mol Genet, 1, pp 103–109.
Blake, D.J., Tinsley, J.M., Davies, K.E., Knight, A.E., Winder, S.J., and Kendrick-Jones, J., 1995, Coiled-coil regions in the carboxy-terminal domains of dystrophin and related proteins: potentials for protein-protein interactions, Trends Biochem Sci, 20, pp 133–135.
Bonuccelli, G., Sotgia, F., Schubert, W., Park, D.S., Frank, P.G., Woodman, S.E., Insabato, L., Cammer,M., Minetti, C., and Lisanti, M.P., 2003, Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins, Am J Pathol, 163, pp 1663–1675.
Bork, P., and Sudol, M., 1994, The WW domain: a signalling site in dystrophin?, Trends Biochem Sci,19, pp 531–533.
Boyce, F.M., Beggs, A.H., Feener, C., and Kunkel, L.M., 1991, Dystrophin is transcribed in brain from a distant upstream promoter, Proc Natl Acad Sci U S A, 88, pp 1276–1280.
Boyd, Y., and Buckle, V.J., 1986, Cytogenetic heterogeneity of translocations associated with Duchenne muscular dystrophy, Clin Genet, 29, pp 108–115.
Bulfield, G., Siller, W.G., Wight, P.A., and Moore, K.J., 1984, X chromosome-linked muscular dystrophy (mdx) in the mouse, Proc Natl Acad Sci U S A, 81, pp 1189–1192.
Burkhard, P., Stetefeld, J., and Strelkov, S.V., 2001, Coiled coils: a highly versatile protein folding motif, Trends Cell Biol, 11, pp 82–88.
Byers, T.J., Lidov, H.G., and Kunkel, L.M., 1993, An alternative dystrophin transcript specific to peripheral nerve, Nat Genet, 4, pp 77–81.
Carlson, C.G., Gueorguiev, A., Roshek, D.M., Ashmore, R., Chu, J.S., and Anderson, J.E., 2003, Extrajunctional resting Ca2+ influx is not increased in a severely dystrophic expiratory muscle (triangularis sterni) of the mdx mouse, Neurobiol Dis, 14, pp 229–239.
Carlson, C.G., and Makiejus, R.V., 1990, A noninvasive procedure to detect muscle weakness in the mdx mouse, Muscle Nerve, 13, pp 480–484.
Carlson, C.G., Samadi, A., and Siegel, A., 2005, Chronic treatment with agents that stabilize cytosolic IkappaB-alpha enhances survival and improves resting membrane potential in MDX muscle fibers subjected to chronic passive stretch, Neurobiol Dis, 20, pp 719–730.
Carpenter, S., and Karpati, G., 1979, Duchenne muscular dystrophy: plasma membrane loss initiates muscle cell necrosis unless it is repaired, Brain, 102, pp 147–161.
Chamberlain, J.S., 1992, X-linked dystrophies: from gene localization to gene therapy, Curr Opin Neurol Neurosurg, 5, pp 610–614.
Chapman, V.M., Miller, D.R., Armstrong, D., and Caskey, C.T., 1989, Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice, Proc Natl Acad Sci U S A, 86, pp 1292–1296.
Chelly, J., Hamard, G., Koulakoff, A., Kaplan, J.C., Kahn, A., and Berwald-Netter, Y., 1990, Dystrophin gene transcribed from different promoters in neuronal and glial cells, Nature, 344, pp 64–65.
Clarke, M.S., Khakee, R., and McNeil, P.L., 1993, Loss of cytoplasmic basic fibroblast growth factor from physiologically wounded myofibers of normal and dystrophic muscle, J Cell Sci, 106 ( Pt 1), pp 121–133.
Coffey, A.J., Roberts, R.G., Green, E.D., Cole, C.G., Butler, R., Anand, R., Giannelli, F., and Bentley, D.R., 1992, Construction of a 2.6-Mb contig in yeast artificial chromosomes spanning the human dystrophin gene using an STS-based approach, Genomics, 12, pp 474–484.
Collet, C., Allard, B., Tourneur, Y., and Jacquemond, V., 1999, Intracellular calcium signals measured with indo-1 in isolated skeletal muscle fibres from control and mdx mice, J Physiol, 520 Pt 2, pp 417–429.
Combaret, L., Taillandier, D., Voisin, L., Samuels, S.E., Boespflug-Tanguy, O., and Attaix, D., 1996, No alteration in gene expression of components of the ubiquitin-proteasome proteolytic pathway in dystrophin-deficient muscles, FEBS Lett, 393, pp 292–296.
Coulombe, A., Lefevre, I.A., Baro, I., and Coraboeuf, E., 1989, Barium- and calcium-permeable channels open at negative membrane potentials in rat ventricular myocytes, J Membr Biol, 111, pp 57–67.
Coulton, G.R., Morgan, J.E., Partridge, T.A., and Sloper, J.C., 1988, The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation, Neuropathol App l Neurobiol, 14, pp 53–70.
Cox, G.A., Phelps, S.F., Chapman, V.M., and Chamberlain, J.S., 1993, New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin, Nat Genet, 4, pp 87–93.
Cox, G.A., Sunada, Y., Campbell, K.P., and Chamberlain, J.S., 1994, Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy, Nat Genet, 8, pp 333–339.
Crawford, G.E., Faulkner, J.A., Crosbie, R.H., Campbell, K.P., Froehner, S.C., and Chamberlain, J.S., 2000, Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain, J Cell Biol, 150, pp 1399–1410.
Culligan, K., Banville, N., Dowling, P., and Ohlendieck, K., 2002, Drastic reduction of calsequestrin-like proteins and impaired calcium binding in dystrophic mdx muscle, J Appl Physiol, 92, pp 435–445.
Dangain, J., and Vrbova, G., 1984, Muscle development in mdx mutant mice, Muscle Nerve, 7, pp 700–704.
Davies, K.E., Pearson, P.L., Harper, P.S., Murray, J.M., O’Brien, T., Sarfarazi, M., and Williamson, R., 1983, Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome, Nucleic Acids Res, 11, pp 2303–2312.
De Backer, F., Vandebrouck, C., Gailly, P., and Gillis, J.M., 2002, Long-term study of Ca(2+) homeostasis and of survival in collagenase-isolated muscle fibres from normal and mdx mice, JPhysiol, 542, pp 855–865.
De Luca, A., Pierno, S., Liantonio, A., Cetrone, M., Camerino, C., Fraysse, B., Mirabella, M., Servidei,S., Ruegg, U.T., and Conte Camerino, D., 2003, Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1, J Pharmacol Exp Ther, 304, pp 453–463.
Deconinck, N., Ragot, T., Marechal, G., Perricaudet, M., and Gillis, J.M., 1996, Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene, Proc Natl Acad Sci U S A, 93, pp 3570–3574.
Desnuelle, C., Renaud, J.F., Delpont, E., Serratrice, G., and Lazdunski, M., 1986, [3H]nitrendipine receptors as markers of a class of putative voltage-sensitive Ca2+ channels in normal human skeletal muscle and in muscle from Duchenne muscular dystrophy patients, Muscle Nerve, 9, pp 148–151.
DiMario, J.X., Uzman, A., and Strohman, R.C., 1991, Fiber regeneration is not persistent in dystrophic (MDX) mouse skeletal muscle, Dev Biol, 148, pp 314–321.
Divet, A., and Huchet-Cadiou, C., 2002, Sarcoplasmic reticulum function in slow- and fast-twitch skeletal muscles from mdx mice, Pflugers Arch, 444, pp 634–643.
Divet, A., Lompre, A.M., and Huchet-Cadiou, C., 2005, Effect of cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum Ca-ATPase, on skeletal muscles from normal and mdx mice, Acta Physiol Scand, 184, pp 173–186.
Doherty, K.R., and McNally, E.M., 2003, Repairing the tears: dysferlin in muscle membrane repair, Trends Mol Med, 9, pp 327–330.
Doran, P., Dowling, P., Donoghue, P., Buffini, M., and Ohlendieck, K., 2006, Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle, Biochim Biophys Acta, 1764, pp 773–785.
Doran, P., Dowling, P., Lohan, J., McDonnell, K., Poetsch, S., and Ohlendieck, K., 2004, Subproteomics analysis of Ca^+-binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle, Eur J Biochem, 271, pp 3943–3952.
Dowling, P., Doran, P., and Ohlendieck, K., 2004, Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy, Biochem J, 379, pp 479–488.
Dunckley, M.G., Wells, D.J., Walsh, F.S., and Dickson, G., 1993, Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo, Hum Mol Genet, 2, pp 717–723.
Dunn, J.F., Bannister, N., Kemp, G.J., and Publicover, S.J., 1993, Sodium is elevated in mdx muscles: ionic interactions in dystrophic cells, J Neurol Sci, 114, pp 76–80.
England, S.B., Nicholson, L.V., Johnson, M.A., Forrest, S.M., Love, D.R., Zubrzycka-Gaarn, E.E., Bulman, D.E., Harris, J.B., and Davies, K.E., 1990, Very mild muscular dystrophy associated with the deletion of 46% of dystrophin, Nature, 343, pp 180–182.
Feener, C.A., Koenig, M., and Kunkel, L.M., 1989, Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus, Nature, 338, pp 509–511.
Ferlini, A., Sewry, C., Melis, M.A., Mateddu, A., and Muntoni, F., 1999, X-linked dilated cardiomyopathy and the dystrophin gene, Neuromuscul Disord, 9, pp 339–346.
Fong, P.Y., Turner, P.R., Denetclaw, W.F., and Steinhardt, R.A., 1990, Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin, Science, 250, pp 673–676.
Franco-Obregon, A., Jr., and Lansman, J.B., 1994, Mechanosensitive ion channels in skeletal muscle from normal and dystrophic mice, J Physiol, 481 ( Pt 2), pp 299–309.
Franco-Obregon, A., and Lansman, J.B., 2002, Changes in mechanosensitive channel gating following mechanical stimulation in skeletal muscle myotubes from the mdx mouse, J Physiol, 539, pp 391–407.
Franco, A., Jr., and Lansman, J.B., 1990, Calcium entry through stretch-inactivated ion channels in mdx myotubes, Nature, 344, pp 670–673.
Fraysse, B., Liantonio, A., Cetrone, M., Burdi, R., Pierno, S., Frigeri, A., Pisoni, M., Camerino, C., and De Luca, A., 2004, The alteration of calcium homeostasis in adult dystrophic mdx muscle fibers is worsened by a chronic exercise in vivo, Neurobiol Dis, 17, pp 144–154.
Friedrich, O., Both, M., Gillis, J.M., Chamberlain, J.S., and Fink, R.H., 2004, Mini-dystrophin restores L-type calcium currents in skeletal muscle of transgenic mdx mice, J Physiol, 555, pp 251–265.
Furuno, K., and Goldberg, A.L., 1986, The activation of protein degradation in muscle by Ca2+ or muscle injury does not involve a lysosomal mechanism, Biochem J, 237, pp 859–864.
Gailly, P., 2002, New aspects of calcium signaling in skeletal muscle cells: implications in Duchenne muscular dystrophy, Biochim Biophys Acta, 1600, pp 38–44.
Gailly, P., Boland, B., Himpens, B., Casteels, R., and Gillis, J.M., 1993, Critical evaluation of cytosolic calcium determination in resting muscle fibres from normal and dystrophic (mdx) mice, Cell Calcium, 14, pp 473–483.
Gardner, R.J., Bobrow, M., and Roberts, R.G., 1995, The identification of point mutations in Duchenne muscular dystrophy patients by using reverse-transcription PCR and the protein truncation test, Am J Hum Genet, 57, pp 311–320.
Ge, Y., Molloy, M.P., Chamberlain, J.S., and Andrews, P.C., 2004, Differential expression of the skeletal muscle proteome in mdx mice at different ages, Electrophoresis, 25, pp 2576–2585.
Gillis, J.M., 1999, Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse, J Muscle Res Cell Motil, 20, pp 605–625.
Goldberg, L.R., Hausmanowa-Petrusewicz, I., Fidzianska, A., Duggan, D.J., Steinberg, L.S., and Hoffman, E.P., 1998, A dystrophin missense mutation showing persistence of dystrophin and dystrophin-associated proteins yet a severe phenotype, Ann Neurol, 44, pp 971–976.
Gorecki, D.C., Monaco, A.P., Derry, J.M., Walker, A.P., Barnard, E.A., and Barnard, P.J., 1992, Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters, Hum Mol Genet, 1, pp 505–510.
Gorospe, J.R.M., Nishikawa, B.K., and Hoffman, E.P., Pathophysiology of dystrophin deficiency: a clinical and biological enigma. In: Dystrophin: Gene, Protein and Cell Biology (S. Brown and J.A.Lucy, eds) Cambridge University Press, Cambridge, UK, pp 201–232.
Granchelli, J.A., Pollina, C., and Hudecki, M.S., 2000, Pre-clinical screening of drugs using the mdx mouse, Neuromuscul Disord, 10, pp 235–239.
Greenberg, D.S., Sunada, Y., Campbell, K.P., Yaffe, D., and Nudel, U., 1994, Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice, Nat Genet, 8, pp 340–344.
Gu, C., Jan, Y.N., and Jan, L.Y., 2003, A conserved domain in axonal targeting of Kv1 (Shaker) voltage-gated potassium channels, Science, 301, pp 646–649.
Gu, C.X., Juranka, P.F., and Morris, C.E., 2001, Stretch-activation and stretch-inactivation of Shaker-IR, a voltage-gated K+ channel, Biophys J, 80, pp 2678–2693.
Hall-Craggs, E.C., and Seyan, H.S., 1975, Histochemical changes in innervated and denervated skeletal muscle fibers following treatment with bupivacaine (marcain), Exp Neurol, 46, pp 345–354.
Halayko, A.J., and Stelmack, G.L., 2005, The association of caveolae, actin, and the dystrophin-glycoprotein complex: a role in smooth muscle phenotype and function?, Can J Physiol Pharmacol, 83, pp 877–891.
Hattori, N., Kaido, M., Nishigaki, T., Inui, K., Fujimura, H., Nishimura, T., Naka, T., and Hazama, T., 1999, Undetectable dystrophin can still result in a relatively benign phenotype of dystrophinopathy, Neuromuscul Disord, 9, pp 220–226.
Helliwell, T.R., Ellis, J.M., Mountford, R.C., Appleton, R.E., and Morris, G.E., 1992, A truncated dystrophin lacking the C-terminal domains is localized at the muscle membrane, Am J Hum Genet, 50, pp 508–514.
Helliwell, T.R., Wilkinson, A., Griffiths, R.D., McClelland, P., Palmer, T.E., and Bone, J.M., 1998, Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin, Neuropathol Appl Neurobiol, 24, pp 507–517.
Hoffman, E.P., Brown, R.H., and Kunkel, L.M., 1992, Dystrophin: the protein product of the Duchene muscular dystrophy locus. 1987, Biotechnology, 24, pp 457–466.
Hoffman, E.P., Garcia, C.A., Chamberlain, J.S., Angelini, C., Lupski, J.R., and Fenwick, R., 1991, Is the carboxyl-terminus of dystrophin required for membrane association? A novel, severe case of Duchenne muscular dystrophy, Ann Neurol, 30, pp 605–610.
Holder, E., Maeda, M., and Bies, R.D., 1996, Expression and regulation of the dystrophin Purkinje promoter in human skeletal muscle, heart, and brain, Hum Genet, 97, pp 232–239.
Hopf, F.W., Reddy, P., Hong, J., and Steinhardt, R.A., 1996a, A capacitative calcium current in cultured skeletal muscle cells is mediated by the calcium-specific leak channel and inhibited by dihydropyridine compounds, J Biol Chem, 271, pp 22358–22367.
Hopf, F.W., Turner, P.R., Denetclaw, W.F., Jr., Reddy, P., and Steinhardt, R.A., 1996b, A critical evaluation of resting intracellular free calcium regulation in dystrophic mdx muscle, Am J Physiol, 271, pp C1325–1339.
Howard, P.L., Dally, G.Y., Ditta, S.D., Austin, R.C., Worton, R.G., Klamut, H.J., and Ray, P.N., 1999, Dystrophin isoforms DP71 and DP427 have distinct roles in myogenic cells, Muscle Nerve, 22, pp 16–27.
Howard, P.L., Dally, G.Y., Wong, M.H., Ho, A., Weleber, R.G., Pillers, D.A., and Ray, P.N., 1998, Localization of dystrophin isoform Dp71 to the inner limiting membrane of the retina suggests a unique functional contribution of Dp71 in the retina, Hum Mol Genet, 7, pp 1385–1391.
Huang, X., Poy, F., Zhang, R., Joachimiak, A., Sudol, M., and Eck, M.J., 2000, Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan, Nat Struct Biol, 7, pp 634–638.
Hugnot, J.P., Gilgenkrantz, H., Vincent, N., Chafey, P., Morris, G.E., Monaco, A.P., Berwald-Netter,Y., Koulakoff, A., Kaplan, J.C., Kahn, A., and et al., 1992, Distal transcript of the dystrophin gene initiated from an alternative first exon and encoding a 75-kDa protein widely distributed in nonmuscle tissues, Proc Natl Acad Sci U S A, 89, pp 7506–7510.
Ibraghimov-Beskrovnaya, O., Ervasti, J.M., Leveille, C.J., Slaughter, C.A., Sernett, S.W., and Campbell, K.P., 1992, Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix, Nature, 355, pp 696–702.
Ibraghimov-Beskrovnaya, O., Milatovich, A., Ozcelik, T., Yang, B., Koepnick, K., Francke, U., and Campbell, K.P., 1993, Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization, Hum Mol Genet, 2, pp 1651–1657.
Im, W.B., Phelps, S.F., Copen, E.H., Adams, E.G., Slightom, J.L., and Chamberlain, J.S., 1996, Differential expression of dystrophin isoforms in strains of mdx mice with different mutations, Hum Mol Genet, 5, pp 1149–1153.
Imbert, N., Cognard, C., Duport, G., Guillou, C., and Raymond, G., 1995, Abnormal calcium homeostasis in Duchenne muscular dystrophy myotubes contracting in vitro, Cell Calcium, 18, pp 177–186.
Imbert, N., Vandebrouck, C., Constantin, B., Duport, G., Guillou, C., Cognard, C., and Raymond, G., 1996, Hypoosmotic shocks induce elevation of resting calcium level in Duchenne muscular dystrophy myotubes contracting in vitro, Neuromuscul Disord, 6, pp 351–360.
Imbert, N., Vandebrouck, C., Duport, G., Raymond, G., Hassoni, A.A., Constantin, B., Cullen, M.J., and Cognard, C., 2001, Calcium currents and transients in co-cultured contracting normal and Duchenne muscular dystrophy human myotubes, J Physiol, 534, pp 343–355.
Iwata, Y., Katanosaka, Y., Arai, Y., Komamura, K., Miyatake, K., and Shigekawa, M., 2003, A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel, J Cell Biol, 161, pp 957–967.
Jackson, M.J., Jones, D.A., and Edwards, R.H., 1984, Experimental skeletal muscle damage: the nature of the calcium-activated degenerative processes, Eur J Clin Invest, 14, pp 369–374.
James, M., Nuttall, A., Ilsley, J.L., Ottersbach, K., Tinsley, J.M., Sudol, M., and Winder, S.J., 2000, Adhesion-dependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin, J Cell Sci, 113 ( Pt 10), pp 1717–1726.
Jin, Y., Murakami, N., Saito, Y., Goto, Y., Koishi, K., and Nonaka, I., 2000, Expression of MyoD and myogenin in dystrophic mice, mdx and dy, during regeneration, Acta Neuropathol (Berl), 99, pp 619–627.
Jung, D., Yang, B., Meyer, J., Chamberlain, J.S., and Campbell, K.P., 1995, Identification and characterization of the dystrophin anchoring site on beta-dystroglycan, J Biol Chem, 270, pp 27305–27310.
Kar, N.C., and Pearson, C.M., 1978, Muscular dystrophy and activation of proteinases, Muscle Nerve, 1, pp 308–313.
Kargacin, M.E., and Kargacin, G.J., 1996, The sarcoplasmic reticulum calcium pump is functionally altered in dystrophic muscle, Biochim Biophys Acta, 1290, pp 4–8.
Kingston, H.M., Harper, P.S., Pearson, P.L., Davies, K.E., Williamson, R., and Page, D., 1983, Localisation of gene for Becker muscular dystrophy, Lancet, 2, pp 1200.
Kiselyov, K., Xu, X., Mozhayeva, G., Kuo, T., Pessah, I., Mignery, G., Zhu, X., Birnbaumer, L., and Muallem, S., 1998, Functional interaction between InsP3 receptors and store-operated Htrp3 channels, Nature, 396, pp 478–482.
Klamut, H.J., Gangopadhyay, S.B., Worton, R.G., and Ray, P.N., 1990, Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene, Mol Cell Biol, 10, pp 193–205.
Koenig, M., Beggs, A.H., Moyer, M., Scherpf, S., Heindrich, K., Bettecken, T., Meng, G., Muller,C.R., Lindlof, M., Kaariainen, H., and et al., 1989, The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion, Am J Hum Genet, 45, pp 498–506.
Koenig, M., Hoffman, E.P., Bertelson, C.J., Monaco, A.P., Feener, C., and Kunkel, L.M., 1987, Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals, Cell, 50, pp 509–517.
Koenig, M., and Kunkel, L.M., 1990, Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility, J Biol Chem, 265, pp 4560–4566.
Koenig, M., Monaco, A.P., and Kunkel, L.M., 1988, The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein, Cell, 53, pp 219–226.
Kumamoto, T., Fujimoto, S., Ito, T., Horinouchi, H., Ueyama, H., and Tsuda, T., 2000, Proteasome expression in the skeletal muscles of patients with muscular dystrophy, Acta Neuropathol (Berl), 100, pp 595–602.
Kumamoto, T., Ueyama, H., Sugihara, R., Kominami, E., Goll, D.E., and Tsuda, T., 1997, Calpain and cathepsins in the skeletal muscle of inflammatory myopathies, Eur Neurol, 37, pp 176–181.
Kumar, A., Khandelwal, N., Malya, R., Reid, M.B., and Boriek, A.M., 2004, Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers, Faseb J, 18, pp 102–113.
Kurebayashi, N., and Ogawa, Y., 2001, Depletion of Ca2+ in the sarcoplasmic reticulum stimulates Ca2+ entry into mouse skeletal muscle fibres, J Physiol, 533, pp 185–199.
Lederfein, D., Levy, Z., Augier, N., Mornet, D., Morris, G., Fuchs, O., Yaffe, D., and Nudel, U., 1992, A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues, Proc Natl Acad Sci U S A, 89, pp 5346–5350.
Leijendekker, W.J., Passaquin, A.C., Metzinger, L., and Ruegg, U.T., 1996, Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress, Br J Pharmacol, 118, pp 611–616.
Lenk, U., Hanke, R., Thiele, H., and Speer, A., 1993, Point mutations at the carboxy terminus of the human dystrophin gene: implications for an association with mental retardation in DMD patients, Hum Mol Genet, 2, pp 1877–1881.
Lenk, U., Oexle, K., Voit, T., Ancker, U., Hellner, K.A., Speer, A., and Hubner, C., 1996, A cysteine 3340 substitution in the dystroglycan-binding domain of dystrophin associated with Duchenne muscular dystrophy, mental retardation and absence of the ERG b-wave, Hum Mol Genet, 5, pp 973–975.
Liberona, J.L., Powell, J.A., Shenoi, S., Petherbridge, L., Caviedes, R., and Jaimovich, E., 1998, Differences in both inositol 1,4,5-trisphosphate mass and inositol 1,4,5-trisphosphate receptors between normal and dystrophic skeletal muscle cell lines, Muscle Nerve, 21, pp 902–909.
Lidov, H.G., Selig, S., and Kunkel, L.M., 1995, Dp140: a novel 140 kDa CNS transcript from the dystrophin locus, Hum Mol Genet, 4, pp 329–335.
Liechti-Gallati, S., Koenig, M., Kunkel, L.M., Frey, D., Boltshauser, E., Schneider, V., Braga, S., and Moser, H., 1989, Molecular deletion patterns in Duchenne and Becker type muscular dystrophy, Hum Genet, 81, pp 343–348.
Lupas, A., 1996, Coiled coils: new structures and new functions, Trends Biochem Sci, 21, pp 375–382.
Lynch, G.S., Hinkle, R.T., Chamberlain, J.S., Brooks, S.V., and Faulkner, J.A., 2001, Force and power output of fast and slow skeletal muscles from mdx mice 6–28 months old, J Physiol, 535, pp 591–600.
Lynch, G.S., Rafael, J.A., Chamberlain, J.S., and Faulkner, J.A., 2000, Contraction-induced injury to single permeabilized muscle fibers from mdx, transgenic mdx, and control mice, Am J Physiol Cell Physiol, 279, pp C1290–1294.
Macias, M.J., Hyvonen, M., Baraldi, E., Schultz, J., Sudol, M., Saraste, M., and Oschkinat, H., 1996, Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide, Nature, 382, pp 646–649.
Makover, A., Zuk, D., Breakstone, J., Yaffe, D., and Nudel, U., 1991, Brain-type and muscle-type promoters of the dystrophin gene differ greatly in structure, Neuromuscul Disord, 1, pp 39–45.
Malhotra, S.B., Hart, K.A., Klamut, H.J., Thomas, N.S., Bodrug, S.E., Burghes, A.H., Bobrow, M., Harper, P.S., Thompson, M.W., Ray, P.N., and et al., 1988, Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy, Science, 242, pp 755–759.
Mallouk, N., Jacquemond, V., and Allard, B., 2000, Elevated subsarcolemmal Ca2+ in mdx mouse skeletal muscle fibers detected with Ca2+-activated K^+ channels, Proc Natl Acad Sci U S A, 97, pp 4950–4955.
Mariol, M.C., and Segalat, L., 2001, Muscular degeneration in the absence of dystrophin is a calcium-dependent process, Curr Biol, 11, pp 1691–1694.
Maroto, R., Raso, A., Wood, T.G., Kurosky, A., Martinac, B., and Hamill, O.P., 2005, TRPC1 forms the stretch-activated cation channel in vertebrate cells, Nat Cell Biol, 7, pp 179–185.
Matsuda, R., Nishikawa, A., and Tanaka, H., 1995, Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle, JBiochem (Tokyo), 118, pp 959–964.
McBride, D.W.,Jr., and Hamill, O.P., 1992, Pressure-clamp: a method for rapid step perturbation of mechanosensitive channels, Pflugers Arch, 421, pp 606–612.
McBride, T.A., Stockert, B.W., Gorin, F.A., and Carlsen, R.C., 2000, Stretch-activated ion channels contribute to membrane depolarization after eccentric contractions, J Appl Physiol, 88, pp 91–101.
McCarter, G.C., and Steinhardt, R.A., 2000, Increased activity of calcium leak channels caused by proteolysis near sarcolemmal ruptures, J Membr Biol, 176, pp 169–174.
McNeil, P.L., and Steinhardt, R.A., 2003, Plasma membrane disruption: repair, prevention, adaptation, Annu Rev Cell Dev Biol, 19, pp 697–731.
Menke, A., and Jockusch, H., 1991, Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse, Nature, 349, pp 69–71.
Monaco, A.P., Bertelson, C.J., Colletti-Feener, C., and Kunkel, L.M., 1987, Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy, Hum Genet, 75, pp 221–227.
Monaco, A.P., Bertelson, C.J., Liechti-Gallati, S., Moser, H., and Kunkel, L.M., 1988, An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus, Genomics, 2, pp 90–95.
Monaco, A.P., Bertelson, C.J., Middlesworth, W., Colletti, C.A., Aldridge, J., Fischbeck, K.H., Bartlett,R., Pericak-Vance, M.A., Roses, A.D., and Kunkel, L.M., 1985, Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment, Nature, 316, pp 842–845.
Monaco, A.P., Neve, R.L., Colletti-Feener, C., Bertelson, C.J., Kurnit, D.M., and Kunkel, L.M., 1986, Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene, Nature, 323, pp 646–650.
Monaco, A.P., Walker, A.P., Millwood, I., Larin, Z., and Lehrach, H., 1992, A yeast artificial chromosome contig containing the complete Duchenne muscular dystrophy gene, Genomics, 12, pp 465–473.
Muntoni, F., 2003, Cardiomyopathy in muscular dystrophies, Curr Opin Neurol, 16, pp 577–583.
Nicolas-Metral, V., Raddatz, E., Kucera, P., and Ruegg, U.T., 2001, Mdx myotubes have normal excitability but show reduced contraction-relaxation dynamics, J Muscle Res Cell Motil, 22, pp 69–75.
Nudel, U., Zuk, D., Einat, P., Zeelon, E., Levy, Z., Neuman, S., and Yaffe, D., 1989, Duchenne muscular dystrophy gene product is not identical in muscle and brain, Nature, 337, pp 76–78.
Pagel, C.N., and Partridge, T.A., 1999, Covert persistence of mdx mouse myopathy is revealed by acute and chronic effects of irradiation, J Neurol Sci, 164, pp 103–116.
Parekh, A.B., and Penner, R., 1997, Store depletion and calcium influx, Physiol Rev, 77, pp 901–930.
Pastoret, C., and Sebille, A., 1995, mdx mice show progressive weakness and muscle deterioration with age, J Neurol Sci, 129, pp 97–105.
Pearson, C.M., and Kar, N.C., 1979, Muscle breakdown and lysosomal activation (biochemistry), Ann N Y Acad Sci, 317, pp 465–477.
Peinelt, C., Vig, M., Koomoa, D.L., Beck, A., Nadler, M.J., Koblan-Huberson, M., Lis, A., Fleig, A., Penner, R., and Kinet, J.P., 2006, Amplification of CRAC current by STIM1 and CRACM1 (Orai1), Nat Cell Biol, 8, pp 771–773.
Pereon, Y., Dettbarn, C., Navarro, J., Noireaud, J., and Palade, P.T., 1997, Dihydropyridine receptor gene expression in skeletal muscle from mdx and control mice, Biochim Biophys Acta, 1362, pp 201–207.
Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M., and Sweeney, H.L., 1993, Dystrophin protects the sarcolemma from stresses developed during muscle contraction, Proc Natl Acad Sci U S A, 90, pp 3710–3714.
Phelps, S.F., Hauser, M.A., Cole, N.M., Rafael, J.A., Hinkle, R.T., Faulkner, J.A., and Chamberlain, J.S., 1995, Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice, Hum Mol Genet, 4, pp 1251–1258.
Ponting, C.P., Blake, D.J., Davies, K.E., Kendrick-Jones, J., and Winder, S.J., 1996, ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins, Trends Biochem Sci, 21, pp 11–13.
Pressmar, J., Brinkmeier, H., Seewald, M.J., Naumann, T., and Rudel, R., 1994, Intracellular Ca2+ concentrations are not elevated in resting cultured muscle from Duchenne (DMD) patients and in MDX mouse muscle fibres, Pflugers Arch, 426, pp 499–505.
Prior, T.W., Bartolo, C., Pearl, D.K., Papp, A.C., Snyder, P.J., Sedra, M.S., Burghes, A.H., and Mendell, J.R., 1995, Spectrum of small mutations in the dystrophin coding region, Am J Hum Genet, 57, pp 22–33.
Rafael, J.A., Cox, G.A., Corrado, K., Jung, D., Campbell, K.P., and Chamberlain, J.S., 1996, Forced expression of dystrophin deletion constructs reveals structure-function correlations, J Cell Biol, 134, pp 93–102.
Rafael, J.A., Nitta, Y., Peters, J., and Davies, K.E., 2000, Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice, Mamm Genome, 11, pp 725–728.
Ragot, T., Vincent, N., Chafey, P., Vigne, E., Gilgenkrantz, H., Couton, D., Cartaud, J., Briand, P., Kaplan, J.C., Perricaudet, M., and et al., 1993, Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice, Nature, 361, pp 647–650.
Rando, T.A., 2001, The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies, Muscle Nerve, 24, pp 1575–1594.
Reddy, P.A., Anandavalli, T.E., and Anandaraj, M.P., 1986, Calcium activated neutral proteases (milli- and micro-CANP) and endogenous CANP inhibitor of muscle in Duchenne muscular dystrophy (DMD), Clin Chim Acta, 160, pp 281–288.
Rentschler, S., Linn, H., Deininger, K., Bedford, M.T., Espanel, X., and Sudol, M., 1999, The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan, Biol Chem, 380, pp 431–442.
Repetto, S., Bado, M., Broda, P., Lucania, G., Masetti, E., Sotgia, F., Carbone, I., Pavan, A., Bonilla,E., Cordone, G., Lisanti, M.P., and Minetti, C., 1999, Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy, Biochem Biophys Res Commun, 261, pp 547–550.
Robert, V., Massimino, M.L., Tosello, V., Marsault, R., Cantini, M., Sorrentino, V., and Pozzan, T., 2001, Alteration in calcium handling at the subcellular level in mdx myotubes, J Biol Chem, 276, pp 4647–4651.
Roberts, R.G., Coffey, A.J., Bobrow, M., and Bentley, D.R., 1993, Exon structure of the human dystrophin gene, Genomics, 16, pp 536–538.
Roberts, R.G., Gardner, R.J., and Bobrow, M., 1994, Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations, Hum Mutat, 4, pp 1–11.
Rohman, M.S., Emoto, N., Takeshima, Y., Yokoyama, M., and Matsuo, M., 2003, Decreased mAKAP, ryanodine receptor, and SERCA2a gene expression in mdx hearts, Biochem Biophys Res Commun, 310, pp 228–235.
Rosa, G., Ceccarini, M., Cavaldesi, M., Zini, M., and Petrucci, T.C., 1996, Localization of the dystrophin binding site at the carboxyl terminus of beta-dystroglycan, Biochem Biophys Res Commun, 223, pp 272–277.
Rybakova, I.N., Amann, K.J., and Ervasti, J.M., 1996, A new model for the interaction of dystrophin with F-actin, J Cell Biol, 135, pp 661–672.
Rybakova, I.N., and Ervasti, J.M., 1997, Dystrophin-glycoprotein complex is monomeric and stabilizes actin filaments in vitro through a lateral association, J Biol Chem, 272, pp 28771–28778.
Sacco, P., Jones, D.A., Dick, J.R., and Vrbova, G., 1992, Contractile properties and susceptibility to exercise-induced damage of normal and mdx mouse tibialis anterior muscle, Clin Sci (Lond), 82, pp 227–236.
Sadeghi, A., Doyle, A.D., and Johnson, B.D., 2002, Regulation of the cardiac L-type Ca2+ channel by the actin-binding proteins alpha-actinin and dystrophin, Am J Physiol Cell Physiol, 282, pp C1502–1511.
Sadoulet-Puccio, H.M., Rajala, M., and Kunkel, L.M., 1997, Dystrobrevin and dystrophin: an interaction through coiled-coil motifs, Proc Natl Acad Sci U S A, 94, pp 12413–12418.
Sarig, R., Mezger-Lallemand, V., Gitelman, I., Davis, C., Fuchs, O., Yaffe, D., and Nudel, U., 1999, Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: differential activity of the Dp71 promoter during development, Hum Mol Genet, 8, pp 1–10.
Schofield, J.N., Blake, D.J., Simmons, C., Morris, G.E., Tinsley, J.M., Davies, K.E., and Edwards, Y.H., 1994, Apo-dystrophin-1 and apo-dystrophin-2, products of the Duchenne muscular dystrophy locus: expression during mouse embryogenesis and in cultured cell lines, Hum Mol Genet, 3, pp 1309–1316.
Serio, R., Bonvissuto, F., and Mule, F., 2001, Altered electrical activity in colonic smooth muscle cells from dystrophic (mdx) mice, Neurogastroenterol Motil, 13, pp 169–175.
Sicinski, P., Geng, Y., Ryder-Cook, A.S., Barnard, E.A., Darlison, M.G., and Barnard, P.J., 1989, The molecular basis of muscular dystrophy in the mdx mouse: a point mutation, Science, 244, pp 1578–1580.
Smalheiser, N.R., and Kim, E., 1995, Purification of cranin, a laminin binding membrane protein. Identity with dystroglycan and reassessment of its carbohydrate moieties, J Biol Chem, 270, pp 15425–15433.
Smalheiser, N.R., and Schwartz, N.B., 1987, Cranin: a laminin-binding protein of cell membranes, Proc Natl Acad Sci U S A, 84, pp 6457–6461.
Sorimachi, H., Imajoh-Ohmi, S., Emori, Y., Kawasaki, H., Ohno, S., Minami, Y., and Suzuki, K., 1989, Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m- and mu-types. Specific expression of the mRNA in skeletal muscle, J Biol Chem, 264, pp 20106–20111.
Sorimachi, H., and Suzuki, K., 2001, The structure of calpain, J Biochem (Tokyo), 129, pp 653–664.
Spencer, M.J., and Mellgren, R.L., 2002, Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology, Hum Mol Genet, 11, pp 2645–2655.
Spencer, M.J., and Tidball, J.G., 1996, Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice, Exp Cell Res, 226, pp 264–272.
Squire, S., Raymackers, J.M., Vandebrouck, C., Potter, A., Tinsley, J., Fisher, R., Gillis, J.M., and Davies, K.E., 2002, Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system, Hum Mol Genet, 11, pp 3333–3344.
Stamler, J.S., and Meissner, G., 2001, Physiology of nitric oxide in skeletal muscle, Physiol Rev, 81, pp 209–237.
Stedman, H.H., Sweeney, H.L., Shrager, J.B., Maguire, H.C., Panettieri, R.A., Petrof, B., Narusawa,M., Leferovich, J.M., Sladky, J.T., and Kelly, A.M., 1991, The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy, Nature, 352, pp 536–539.
Suzuki, A., Yoshida, M., Hayashi, K., Mizuno, Y., Hagiwara, Y., and Ozawa, E., 1994, Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin, Eur J Biochem, 220, pp 283–292.
Suzuki, A., Yoshida, M., Yamamoto, H., and Ozawa, E., 1992, Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain, FEBS Lett, 308, pp 154–160.
Tanabe, Y., Esaki, K., and Nomura, T., 1986, Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse, Acta Neuropathol (Berl), 69, pp 91–95.
Trautmann, A., Delaporte, C., and Marty, A., 1986, Voltage-dependent channels of human muscle cultures, Pflugers Arch, 406, pp 163–172.
Turner, P.R., Fong, P.Y., Denetclaw, W.F., and Steinhardt, R.A., 1991, Increased calcium influx in dystrophic muscle, J Cell Biol, 115, pp 1701–1712.
Turner, P.R., Schultz, R., Ganguly, B., and Steinhardt, R.A., 1993, Proteolysis results in altered leak channel kinetics and elevated free calcium in mdx muscle, J Membr Biol, 133, pp 243–251.
Turner, P.R., Westwood, T., Regen, C.M., and Steinhardt, R.A., 1988, Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice, Nature, 335, pp 735–738.
Tutdibi, O., Brinkmeier, H., Rudel, R., and Fohr, K.J., 1999, Increased calcium entry into dystrophin-deficient muscle fibres of MDX and ADR-MDX mice is reduced by ion channel blockers, J Physiol, 515 ( Pt 3), pp 859–868.
Vainzof, M., Takata, R.I., Passos-Bueno, M.R., Pavanello, R.C., and Zatz, M., 1993, Is the maintainance of the C-terminus domain of dystrophin enough to ensure a milder Becker muscular dystrophy phenotype?, Hum Mol Genet, 2, pp 39–42.
Vandebrouck, A., Ducret, T., Basset, O., Sebille, S., Raymond, G., Ruegg, U., Gailly, P., Cognard, C., and Constantin, B., 2006, Regulation of store-operated calcium entries and mitochondrial uptake by minidystrophin expression in cultured myotubes, Faseb J, 20, pp 136–138.
Vandebrouck, C., Duport, G., Cognard, C., and Raymond, G., 2001, Cationic channels in normal and dystrophic human myotubes, Neuromuscul Disord, 11, pp 72–79.
Vandebrouck, C., Duport, G., Raymond, G., and Cognard, C., 2002a, Hypotonic medium increases calcium permeant channels activity in human normal and dystrophic myotubes, Neurosci Lett, 323, pp 239–243.
Vandebrouck, C., Martin, D., Colson-Van Schoor, M., Debaix, H., and Gailly, P., 2002b, Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers, J Cell Biol, 158, pp 1089–1096.
Voisin, L., Breuille, D., Combaret, L., Pouyet, C., Taillandier, D., Aurousseau, E., Obled, C., and Attaix,D., 1996, Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+-activated, and ubiquitin-proteasome proteolytic pathways, J Clin Invest, 97, pp 1610–1617.
Volonte, D., Peoples, A.J., and Galbiati, F., 2003, Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C, Mol Biol Cell, 14, pp 4075–4088.
Wang, X., Weisleder, N., Collet, C., Zhou, J., Chu, Y., Hirata, Y., Zhao, X., Pan, Z., Brotto, M., Cheng, H., and Ma, J., 2005, Uncontrolled calcium sparks act as a dystrophic signal for mammalian skeletal muscle, Nat Cell Biol, 7, pp 525–530.
Weller, B., Karpati, G., and Carpenter, S., 1990, Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions, J Neurol Sci, 100, pp 9–13.
Wells, D.J., Wells, K.E., Asante, E.A., Turner, G., Sunada, Y., Campbell, K.P., Walsh, F.S., and Dickson,G., 1995, Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy, Hum Mol Genet, 4, pp 1245–1250.
Wertz, K., and Fuchtbauer, E.M., 1998, Dmd(mdx-beta geo): a new allele for the mouse dystrophin gene, Dev Dyn, 212, pp 229–241.
Williams, T.M., and Lisanti, M.P., 2004, The caveolin proteins, Genome Biol, 5, pp 214.
Winder, S.J., Gibson, T.J., and Kendrick-Jones, J., 1995, Dystrophin and utrophin: the missing links!, FEBS Lett, 369, pp 27–33.
Winnard, A.V., Klein, C.J., Coovert, D.D., Prior, T., Papp, A., Snyder, P., Bulman, D.E., Ray, P.N., McAndrew, P., King, W., and et al., 1993, Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy, Hum Mol Genet, 2, pp 737–744.
Woods, C.E., Novo, D., DiFranco, M., Capote, J., and Vergara, J.L., 2005, Propagation in the transverse tubular system and voltage dependence of calcium release in normal and mdx mouse muscle fibres, J Physiol, 568, pp 867–880.
Woolf, P.J., Lu, S., Cornford-Nairn, R., Watson, M., Xiao, X.H., Holroyd, S.M., Brown, L., and Hoey,A.J., 2006, Alterations in dihydropyridine receptors in dystrophin-deficient cardiac muscle, Am J Physiol Heart Circ Physiol, 290, pp H2439–2445.
Yang, B., Jung, D., Motto, D., Meyer, J., Koretzky, G., and Campbell, K.P., 1995, SH3 domain-mediated interaction of dystroglycan and Grb2, J Biol Chem, 270, pp 11711–11714.
Yasuda, S., Townsend, D., Michele, D.E., Favre, E.G., Day, S.M., and Metzger, J.M., 2005, Dystrophic heart failure blocked by membrane sealant poloxamer, Nature, 436, pp 1025–1029.
Yeung, E.W., Head, S.I., and Allen, D.G., 2003, Gadolinium reduces short-term stretch-induced muscle damage in isolated mdx mouse muscle fibres, J Physiol, 552, pp 449–458.
Yeung, E.W., Whitehead, N.P., Suchyna, T.M., Gottlieb, P.A., Sachs, F., and Allen, D.G., 2005, Effects of stretch-activated channel blockers on [Ca2+]i and muscle damage in the mdx mouse, J Physiol, 562, pp 367–380.
Yoshida, M., Suzuki, A., Yamamoto, H., Noguchi, S., Mizuno, Y., and Ozawa, E., 1994, Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside, Eur J Biochem, 222, pp 1055–1061.
Zeman, R.J., Kameyama, T., Matsumoto, K., Bernstein, P., and Etlinger, J.D., 1985, Regulation of protein degradation in muscle by calcium. Evidence for enhanced nonlysosomal proteolysis associated with elevated cytosolic calcium, J Biol Chem, 260, pp 13619–13624.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
HOPF, F., TURNER, P., STEINHARDT, R. (2007). Calcium Misregulation and the Pathogenesis of Muscular Dystrophy. In: Carafoli, E., Brini, M. (eds) Calcium Signalling and Disease. Subcellular Biochemistry, vol 45. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-6191-2_16
Download citation
DOI: https://doi.org/10.1007/978-1-4020-6191-2_16
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-6190-5
Online ISBN: 978-1-4020-6191-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)